Q32 Bio Inc. Proceeds from Debt, Net of Issuance Costs
Q32 Bio Inc. (FIXX) reported Proceeds from Debt, Net of Issuance Costs of $13.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-08-05
- 2026-06-30: Proceeds from Debt, Net of Issuance Costs 6 month $13.49M.
- 2025-06-30: Proceeds from Debt, Net of Issuance Costs 6 month $0.00.
| Period end | Proceeds from Debt, Net of Issuance Costs 6 month |
|---|---|
| 2026-06-30 | $13.49M 10-Q · filed 2026-08-05 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 |